The protein KMT SET and MYND domain 3 (SMYD3) is also highly expressed in PCa (12–14); however, whether it has a direct molecular role in promoting aggressive phenotypes associated with advanced prostate adenocarcinoma has not been clearly defined. This evidence concerns the gene SMYD3 and posterior cortical atrophy.